-
1
المؤلفون: Jones, Ben, Buenaventura, Teresa, Kanda, Nisha, Chabosseau, Pauline, Owen, Bryn M., Scott, Rebecca, Goldin, Robert, Angkathunyakul, Napat, Corrêa Jr, Ivan R., Bosco, Domenico, Johnson, Paul R., Piemonti, Lorenzo, Marchetti, Piero, Shapiro, A. M. James, Cochran, Blake J., Hanyaloglu, Aylin C., Inoue, Asuka, Tan, Tricia, Rutter, Guy A., Tomas, Alejandra, Bloom, Stephen R.
المساهمون: Medical Research Council, Medical Research Council (MRC), National Institute for Health Research, Biotechnology and Biological Sciences Research Council (BBSRC), Wellcome Trust, Diabetes UK, The Leverhulme Trust, Juvenile Diabetes Research Foundation International, Rosetrees Trust, Institut De Recherches Servier, Jones, Ben, Buenaventura, Teresa, Kanda, Nisha, Chabosseau, Pauline, Owen, Bryn M, Scott, Rebecca, Goldin, Robert, Angkathunyakul, Napat, Corrêa, Ivan R, Bosco, Domenico, Johnson, Paul R, Piemonti, Lorenzo, Marchetti, Piero, Shapiro, A M Jame, Cochran, Blake J, Hanyaloglu, Aylin C, Inoue, Asuka, Tan, Tricia, Rutter, Guy A, Tomas, Alejandra, Bloom, Stephen R
المصدر: Nature Communications, Vol 9, Iss 1, Pp 1-17 (2018)
Nature Communications
Nature Communications, Vol. 9, No 1 (2018) P. 1602مصطلحات موضوعية: Blood Glucose, Male, Genetics and Molecular Biology (all), FOOD-INTAKE, Inbred C57BL, Biochemistry, ACTIVATION, Mice, Glucagon-Like Peptide 1/metabolism, Glucagon-Like Peptide 1, Insulin-Secreting Cells, Insulin, RNA, Small Interfering, lcsh:Science, Type 2/blood/drug therapy/pathology, Nausea/chemically induced/epidemiology, Cell Membrane/drug effects/metabolism, GLUCAGON-LIKE PEPTIDE-1, ddc:617, digestive, oral, and skin physiology, Chemistry (all), Nausea, OPEN-LABEL, Endocytosis, Multidisciplinary Sciences, Protein Transport, Treatment Outcome, Hypoglycemic Agents/pharmacology/therapeutic use, Science & Technology - Other Topics, hormones, hormone substitutes, and hormone antagonists, endocrine system, Small Interfering/metabolism, Science, Glucagon-Like Peptide-1 Receptor/agonists/metabolism, Insulin-Secreting Cells/drug effects/metabolism, Primary Cell Culture, INDUCED INTERNALIZATION, CHO Cells, Endocytosis/drug effects, INSULIN-SECRETION, Article, Glucagon-Like Peptide-1 Receptor, REDUCES BLOOD-PRESSURE, Diabetes Mellitus, Experimental, Experimental, Physics and Astronomy (all), Blood Glucose/drug effects, Cricetulus, BETA-CELL FUNCTION, ANALOG, Diabetes Mellitus, Animals, Humans, Hypoglycemic Agents, Insulin/genetics/metabolism, Science & Technology, Cell Membrane, Protein Transport/drug effects, Mice, Inbred C57BL, HEK293 Cells, Diabetes Mellitus, Type 2, LIRAGLUTIDE, RNA, lcsh:Q, Biochemistry, Genetics and Molecular Biology (all)
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::29edcc8c94339b28e9b6b71393fb46d1Test
http://hdl.handle.net/10097/00128198Test -
2
المؤلفون: Michael Horowitz, Christopher K. Rayner, Karen L. Jones
المساهمون: Horowitz, Michael, Rayner, Christopher K, Jones, Karen L
المصدر: Advances in Therapy. 30(2):81-101
مصطلحات موضوعية: Blood Glucose, medicine.medical_specialty, endocrine system, endocrine system diseases, medicine.medical_treatment, exenatide, Type 2 diabetes, Pharmacology, Hypoglycemia, Glucagon-Like Peptide-1 Receptor, Lixisenatide, chemistry.chemical_compound, gastric emptying, Internal medicine, Type 2 diabetes mellitus, medicine, Receptors, Glucagon, Humans, Hypoglycemic Agents, incretin therapies, postprandial plasma glucose, Pharmacology (medical), glucagon-like peptide-1 receptor agonists, Glycated Hemoglobin, Medicine(all), liraglutide, Gastric emptying, Liraglutide, business.industry, Insulin, digestive, oral, and skin physiology, nutritional and metabolic diseases, General Medicine, medicine.disease, Postprandial, Endocrinology, hypoglycemia, Treatment Outcome, chemistry, Diabetes Mellitus, Type 2, business, Peptides, Exenatide, lixisenatide, pharmacokinetics, hormones, hormone substitutes, and hormone antagonists, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64bf100b37016c9d5d7a1790d6c4c7c1Test
-
3
المؤلفون: Keith C. Ferdinand, Charles Atisso, Fady T. Botros, Philip T. Sager
المصدر: Cardiovascular Diabetology
مصطلحات موضوعية: Blood Glucose, Male, Endocrinology, Diabetes and Metabolism, Glucagon-Like Peptides, Kaplan-Meier Estimate, 030204 cardiovascular system & hematology, 0302 clinical medicine, Risk Factors, Clinical endpoint, Medicine, Myocardial infarction, Prospective Studies, Stroke, Original Investigation, Randomized Controlled Trials as Topic, Hazard ratio, Type 2 diabetes, Incretin, Middle Aged, Treatment Outcome, Cardiovascular Diseases, Female, Cardiology and Cardiovascular Medicine, medicine.drug, medicine.medical_specialty, Recombinant Fusion Proteins, 030209 endocrinology & metabolism, MACE, Risk Assessment, Drug Administration Schedule, Glucagon-Like Peptide-1 Receptor, Cardiovascular events, 03 medical and health sciences, Internal medicine, Humans, Hypoglycemic Agents, Aged, Proportional Hazards Models, business.industry, Proportional hazards model, Unstable angina, Protective Factors, medicine.disease, Immunoglobulin Fc Fragments, Meta-analysis, Clinical Trials, Phase III as Topic, Diabetes Mellitus, Type 2, Dulaglutide, business, Mace, Biomarkers, Glucagon-like peptide-1 (GLP-1)
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03facb7cc158ef8edd4e179368bb1809Test